SCNI

Scinai Immunotherapeutics

8 hedge funds and large institutions have $3.12M invested in Scinai Immunotherapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
-3
Holders Change %
-27.27%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
2
Increased
3
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
II
1
Ibex Investors
Colorado
$2.75M -$13.9K -18 -0.5%
Renaissance Technologies
2
Renaissance Technologies
New York
$163K +$53.1K +69 +48%
HighTower Advisors
3
HighTower Advisors
Illinois
$146K +$16.2K +21 +13%
Royal Bank of Canada
4
Royal Bank of Canada
Ontario, Canada
$27K +$20.1K +26 +289%
Osaic Holdings
5
Osaic Holdings
Arizona
$19K +$19K +25 New
Wells Fargo
6
Wells Fargo
California
$7K
Morgan Stanley
7
Morgan Stanley
New York
$2K -$5K -5 -71%
JPMorgan Chase & Co
8
JPMorgan Chase & Co
New York
$1K +$1K +2 New
Mariner
9
Mariner
Kansas
-$525K -566 Closed
BHB
10
Bank Hapoalim BM
Israel
-$232K -249 Closed
Deutsche Bank
11
Deutsche Bank
Germany
-$1K -2 Closed